prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |review
Is patient data well anaylzed by locality, income, age, sex, etc. Would questionaires help? Are these patients rural, migrant or urban? How does amebiasis relate to rural poverty? Where did certain travelers become infected? Is amebiasis a medical, a water-and-drainage or a social problem? Is underfinancing of research a problem? What distinguishes persons with antibodies against E. histolytica from others without?